- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nykode Therapeutics ASA (NYKD)Nykode Therapeutics ASA stock price live, this page displays OL NYKD stock exchange data. View the NYKD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Nykode Therapeutics ASA real time stock price chart below.
What Is the Nykode Therapeutics ASA Stock Price Today?
The Nykode Therapeutics ASA stock price today is 2.83.
What Is the Stock Symbol for Nykode Therapeutics ASA?
The stock symbol for Nykode Therapeutics ASA is "NYKD."
What Stock Exchange Does Nykode Therapeutics ASA Trade On?
Nykode Therapeutics ASA is listed and trades on the Oslo stock exchange.
Is Nykode Therapeutics ASA a Good Stock to Buy?
Determining whether Nykode Therapeutics ASA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NYKD quote. (ISIN: NO0010714785)
What Is the Nykode Therapeutics ASA Stock Price Today?
The Nykode Therapeutics ASA stock price today is 2.83.
What Is the Stock Symbol for Nykode Therapeutics ASA?
The stock symbol for Nykode Therapeutics ASA is "NYKD."
What Stock Exchange Does Nykode Therapeutics ASA Trade On?
Nykode Therapeutics ASA is listed and trades on the Oslo stock exchange.
Is Nykode Therapeutics ASA a Good Stock to Buy?
Determining whether Nykode Therapeutics ASA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NYKD quote. (ISIN: NO0010714785)
2.83
-0.08(-2.75%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.82
2.99
52 wk Range
1.55
21.40
NYKD Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.822.99
52 wk Range
1.5521.40
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockNYKD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Neutral
Price Target
17.75
Upside
+527.21%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Nykode Therapeutics Company Profile
Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies. The company develops vaccines for the treatment cancer and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of ,melanoma, lung, bladder, renal, head, and neck cancer; VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer; and VB10. COV2, a COVID-19 vaccine candidate covers new SARS-CoV-2 variants. The company has collaboration agreements with Roche, Genentech, MSD, and Nektar Therapeutics; Adaptive Biotechnologies for T cell vaccine development; and research agreement with Regeneron. Nykode Therapeutics AS was founded in 2006 and is based in Oslo, Norway.
Compare NYKD to Peers and Sector
Metrics to compare | NYKD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNYKDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.3x | −2.8x | −0.7x | |
PEG Ratio | −0.34 | −0.01 | 0.00 | |
Price/Book | 0.6x | 1.2x | 2.6x | |
Price / LTM Sales | 19.6x | 6.1x | 3.2x | |
Upside (Analyst Target) | 194.1% | 525.0% | 45.9% | |
Fair Value Upside | Unlock | 15.6% | 7.6% | Unlock |
Analysts' Recommendations
3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 17.75
(+527.21% Upside)
FAQ
What Is the Nykode Therapeutics (NYKD) Stock Price Today?
The Nykode Therapeutics stock price today is 2.83.
What Stock Exchange Does Nykode Therapeutics Trade On?
Nykode Therapeutics is listed and trades on the Oslo stock exchange.
What Is the Stock Symbol for Nykode Therapeutics?
The stock symbol for Nykode Therapeutics is "NYKD."
What Is the Nykode Therapeutics Market Cap?
As of today, Nykode Therapeutics market cap is 924.13M.
What is Nykode Therapeutics Earnings Per Share?
The Nykode Therapeutics EPS is -0.13.
From a Technical Analysis Perspective, Is NYKD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.